High tissue density of FOXP3+ T cells is associated with clinical outcome in prostate cancer
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference44 articles.
1. Cancer statistics, 2009;Jemal;CA Cancer J Clin,2009
2. Prostate cancer immunology: biology, therapeutics, and challenges;Webster;J Clin Oncol,2005
3. Sipuleucel-T immunotherapy for castration- resistant prostate cancer;Kantoff;N Engl J Med,2010
4. Tumor-infiltrating T lymphocytes: friends or foes?;Yu;Lab Invest,2006
5. Regulatory T cells in tumor immunity;Nishikawa;Int J Cancer,2010
Cited by 98 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Role of tumor microenvironment in prostate cancer therapy resistance;Therapy Resistance in Prostate Cancer;2024
2. Approaches for boosting antitumor immunity in prostate cancer therapy: A comprehensive review on drugs, products, and nanoparticles;Journal of Drug Delivery Science and Technology;2023-11
3. A new histone deacetylase inhibitor remodels the tumor microenvironment by deletion of polymorphonuclear myeloid-derived suppressor cells and sensitizes prostate cancer to immunotherapy;BMC Medicine;2023-10-25
4. Identification and validation of immune-related hub genes based on machine learning in prostate cancer and AOX1 is an oxidative stress-related biomarker;Frontiers in Oncology;2023-07-31
5. New insights and options into the mechanisms and effects of combined targeted therapy and immunotherapy in prostate cancer;Molecular Therapy - Oncolytics;2023-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3